Houillier, Caroline
Choquet, Sylvain
Article History
Accepted: 26 September 2024
First Online: 28 October 2024
Declarations
:
: Caroline Houillier declares no conflict of interest. Sylvain Choquet has received consultant fees from Atara, Pierre Fabre, Astra Zeneca, Novartis and Takeda; has received honoraria for presentations from Pierre Fabre, Takeda, Novartis, Gilead, Janssen; has received support for attending meetings from Pierre Fabre, Janssen.
: All reported studies with human subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).